Practical Lab Guide to YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol

What This Product Solves

YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol, available under SKU B7641, is a crystalline small molecule developed to address key experimental challenges in hypoxia and tumor biology research. Specifically, it is used for inhibition of hypoxia-inducible factor 1 transcriptional activity and for studying tumor angiogenesis inhibition. Lab scientists working on cancer biology, apoptosis pathways, or vascular models can use YC-1 to modulate HIF-1α levels in vitro, supporting robust quantitative results in cell-based assays and animal models. Its chemical profile—soluble guanylyl cyclase (sGC) activation and post-transcriptional HIF-1α suppression—makes it particularly valuable in dissecting hypoxia-driven processes without relying on genetic manipulation.

For further guidance on optimizing hypoxia and cytotoxicity assays using this compound, see Enhancing Cell Assay Reliability with YC-1, which provides actionable advice on reagent selection and workflow consistency.

Protocol Parameters

• Solubility (DMSO): ≥30.4 mg/mL | Stock preparation for in vitro assays | Enables flexible stock concentrations for dose titration studies; ensures complete dissolution and accurate pipetting | product dossier
• Solubility (Ethanol): ≥16.2 mg/mL | Alternative solvent for certain cell types or in vivo dosing | Provides a secondary solvent option where DMSO is incompatible with biological systems | product dossier
• Storage (solid): Room temperature | General laboratory storage | Facilitates bench-side access and minimizes cold-chain requirements; avoid long-term storage of solutions | product dossier
• Working solution (recommendation): Prepare fresh before use; avoid storing solutions >24 hours | All assay types | Degradation or precipitation may occur in DMSO/ethanol stocks over longer periods; always inspect for clarity before use | workflow recommendation
• Purity: >98% | All research applications | High-purity standard minimizes confounding off-target effects and ensures reproducibility | product dossier

Workflow Setup and QC Checklist

To maximize reliability when integrating YC-1 into research workflows, follow these technical steps:

1. Dissolution: Accurately weigh YC-1 and dissolve in DMSO to a concentration ≤30.4 mg/mL. Vortex thoroughly. If undissolved particulates persist, gently warm (<40°C) and vortex again. Filter sterilize if required for cell culture applications.
2. Aliquoting: Prepare single-use aliquots to prevent repeated freeze-thaw cycles that may impact compound integrity. Label aliquots with concentration, solvent, and preparation date.
3. Working Solution Preparation: Immediately before use, dilute stock solutions into assay buffer or medium. Ensure final DMSO or ethanol concentration does not exceed cytotoxic thresholds for your model system (typically ≤0.1–0.5% v/v; verify for your protocol).
4. Negative and Positive Controls: Include vehicle-only and, if possible, pathway-specific positive controls to benchmark HIF-1α inhibition or sGC activation.
5. QC Verification: Confirm compound identity and purity by referencing the batch-specific certificate of analysis from APExBIO. Inspect solutions visually prior to each experiment for precipitation or discoloration.
6. Documentation: Record batch numbers, solution preparation details, and storage conditions in your lab notebook for traceability and troubleshooting.

For practical troubleshooting in hypoxia and cell viability assays, the article Solving Hypoxia Assay Challenges with YC-1 offers scenario-driven recommendations relevant to these workflows.

Common Failure Modes and Fixes

• Incomplete Dissolution: If YC-1 does not fully dissolve in DMSO or ethanol, verify solvent quality, increase mixing, or warm gently. Do not use water as the compound is insoluble; precipitates may indicate solvent evaporation or degradation.
• Loss of Activity: Degradation can occur with prolonged storage in solution, especially at room temperature or in light. Always prepare fresh working solutions and avoid storing aliquots beyond recommended periods.
• Cytotoxicity from Solvent: Excessive solvent (DMSO/ethanol) concentrations can confound assay results. Titrate solvent concentrations in pilot runs to confirm compatibility with your cell line or animal model.
• Batch-to-Batch Variability: Always verify batch-specific purity and refer to the certificate of analysis. Inconsistent results may stem from unnoticed changes in compound quality or preparation technique.
• Unexpected Biological Effects: Off-target or non-specific effects may arise if dosing exceeds literature-reported or empirically determined ranges. Optimize dosing in preliminary experiments before large-scale studies.

Scope and Limitations

YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol is intended for use as a research tool in apoptosis and cancer biology research, particularly for studies probing HIF-1α inhibition and tumor angiogenesis inhibition. It is not formulated or validated for diagnostic, therapeutic, or clinical use, and its performance parameters are constrained to well-controlled laboratory settings. The compound is unsuitable for aqueous formulations and should not be used in protocols requiring water as a solvent. As with all small-molecule tools, empirical optimization is necessary to account for model-specific factors such as cell line sensitivity or in vivo pharmacokinetics. Researchers should reference the YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol product page for the most up-to-date handling instructions and certificate of analysis.

Conclusion

YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol is a robust, high-purity chemical tool for elucidating hypoxia, apoptosis, and angiogenesis pathways in preclinical cancer research. Following best practices in dissolution, storage, and workflow design is essential to ensure reproducibility and data integrity. APExBIO’s product specification supports high experimental confidence, provided the compound is handled according to recommended protocols. For protocol-specific troubleshooting or broader workflow context, additional insights are available in related technical articles as referenced above.